
Wednesday, January 11, 2023 9:59:26 PM

Liked By
Spread the love. Be the first to like this post!
Recent MNMD News
- Securities Registration: Employee Benefit Plan (s-8) • Edgar (US Regulatory) • 03/14/2023 08:19:21 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/13/2023 11:02:17 AM
- Annual Report (10-k) • Edgar (US Regulatory) • 03/09/2023 09:26:08 PM
- MindMed Reports Full Year 2022 Financial Results and Business Highlights • Business Wire • 03/09/2023 09:02:00 PM
- MindMed to Participate in March Investor Conferences • Business Wire • 02/28/2023 12:30:00 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 04:22:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/09/2023 09:32:15 PM
- MindMed Provides Corporate Update and 2023 Outlook • PR Newswire (Canada) • 01/09/2023 12:30:00 PM
- MindMed Provides Corporate Update and 2023 Outlook • PR Newswire (US) • 01/09/2023 12:30:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/22/2022 09:38:41 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/22/2022 09:33:18 PM
- MindMed to Participate in the Canaccord Genuity New Paradigms and Treatment Approaches in Mental Health Conference • PR Newswire (Canada) • 12/01/2022 12:30:00 PM
- MindMed to Participate in the Canaccord Genuity New Paradigms and Treatment Approaches in Mental Health Conference • PR Newswire (US) • 12/01/2022 12:30:00 PM
- Activist Investor Informs MindMed of Financial Misstatements, Questions Internal Controls • GlobeNewswire Inc. • 11/14/2022 01:08:00 PM
- MindMed to Participate in the Jefferies London Healthcare Conference • PR Newswire (US) • 11/11/2022 12:30:00 PM
- MindMed to Participate in the Jefferies London Healthcare Conference • PR Newswire (Canada) • 11/11/2022 12:30:00 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/10/2022 01:22:53 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/10/2022 01:11:56 PM
- MindMed Reports Third Quarter 2022 Financial Results and Business Highlights • PR Newswire (US) • 11/10/2022 01:05:00 PM
- MindMed Reports Third Quarter 2022 Financial Results and Business Highlights • PR Newswire (Canada) • 11/10/2022 01:05:00 PM
- Significant MindMed Investor Demands Federal Investigation to Probe Serious Allegations of Misconduct • GlobeNewswire Inc. • 11/03/2022 12:08:17 PM
- MindMed to Host Earnings Call to Discuss Third Quarter 2022 Financial Results and Provide Business Update • PR Newswire (US) • 11/03/2022 11:30:00 AM
- MindMed to Host Earnings Call to Discuss Third Quarter 2022 Financial Results and Provide Business Update • PR Newswire (Canada) • 11/03/2022 11:30:00 AM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 10/18/2022 08:35:35 PM
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 10/07/2022 09:16:13 PM
FEATURED Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • Mar 31, 2023 7:07 AM
ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM
Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM
ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM
Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM
OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM